Finch Therapeutics Group, Inc. (FNCH)

USD 10.71

(-3.51%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019
Revenue 107 Thousand 861 Thousand 18.53 Million 7.71 Million 10.15 Million
Cost of Revenue 7.19 Million 5.5 Million 57.27 Million 33.14 Million 314 Thousand
Gross Profit -7.09 Million -4.64 Million -38.74 Million -25.42 Million 9.84 Million
Operating Expenses 32.58 Million 95.98 Million 78.51 Million 47.15 Million 30.98 Million
Selling, General and Administrative Expenses 26.91 Million 38.08 Million 21.23 Million 14.01 Million 7.43 Million
Research and Development Expenses 7.19 Million 57.89 Million 57.27 Million 33.14 Million 23.54 Million
Other Expenses - 947 Thousand 1.82 Million 2000.00 40 Thousand
Cost and Expenses 34.1 Million 95.98 Million 78.51 Million 47.15 Million 31.29 Million
Operating Income -34 Million -115.59 Million -59.98 Million -39.43 Million -21.14 Million
Interest Expense - 35.43 Million - - -
Income Tax Expense -3.46 Million -947 Thousand -2.3 Million -93 Thousand -348 Thousand
Earnings before Tax -78.21 Million -114.64 Million -58.16 Million -39.34 Million -20.75 Million
Net Income -74.75 Million -113.69 Million -55.85 Million -39.24 Million -20.4 Million
Earnings Per Share Basic -46.59 -71.52 -35.27 -24.39 -12.68
Earnings Per Share Diluted -46.59 -71.52 -35.27 -24.39 -12.68
Weighted Average Shares Outstanding 1.6 Million 1.58 Million 1.58 Million 1.6 Million 1.6 Million
Weighted Average Shares Outstanding (Diluted) 1.6 Million 1.58 Million 1.58 Million 1.6 Million 1.6 Million
Gross Margin -66.28 -5.40 -2.09 -3.29 0.97
EBIT Margin -303.57 -86.70 -3.24 -5.00 -2.02
Profit Margin -698.64 -132.05 -3.01 -5.08 -2.01
EBITDA -32.48 Million -82.68 Million -57.68 Million -38.64 Million -20.66 Million
Earnings Before Tax Margin -317.78 -134.25 -3.24 -5.11 -2.08

Income Statement Charts